Glycemic control among pregnant diabetic women on insulin who fasted during Ramadan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Ramadan fasting for pregnant women with diabetes remains controversial and underreported. The objective of this study was to determine the glycemic control in pregnant diabetic women on insulin who fasted during Ramadan. Methods: This was a retrospective study carried out over a period of three years including pregnant diabetic women, who were on short-acting, intermediate-acting, or a combination of them, and opted to carry out Ramadan fasting. Glycemic control was assessed before, middle and after Ramadan fasting. Results: Thirty seven women opted to fast with 24 (64.9%) of them had type 2 diabetes mellitus and 83.8% of them required combined insulin (short- acting, intermediate-acting) therapy. The age of the participants was 32.13±4.68 years, and the age of their pregnancies was 25.60±7.12 weeks when the study was performed. The median number of days fasted was 25 days, and most of the women were able to fast for more than 15 days. There was no difference between glycemic control of type 2 diabetes mellitus and gestational diabetes mellitus women prior to fasting. In the middle of Ramadan, serum fructosamine decreased in both groups. However, only serum HbA1c reduced in gestational diabetes mellitus after Ramadan. Conclusion: the findings indicate that pregnant diabetic women on insulin were able to fast during Ramadan and that their glycemic control was improved during fasting period. They may also suggest that instead of absolute ban on fasting for pregnant diabetic women more practical approach and close consultation with health care providers might be more helpful.

Original languageEnglish
Pages (from-to)254-259
Number of pages6
JournalIranian Journal of Medical Sciences
Volume36
Issue number4
Publication statusPublished - Dec 2011

Fingerprint

Pregnant Women
Fasting
Insulin
Gestational Diabetes
Type 2 Diabetes Mellitus
Short-Acting Insulin
Fructosamine
Serum
Health Personnel
Referral and Consultation
Retrospective Studies
Pregnancy
Therapeutics

Keywords

  • Diabetes
  • Fasting
  • Insulin
  • Pregnancy gestational diabetes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{1c2b9b05451d477f8ac05e96a6ff4daf,
title = "Glycemic control among pregnant diabetic women on insulin who fasted during Ramadan",
abstract = "Background: Ramadan fasting for pregnant women with diabetes remains controversial and underreported. The objective of this study was to determine the glycemic control in pregnant diabetic women on insulin who fasted during Ramadan. Methods: This was a retrospective study carried out over a period of three years including pregnant diabetic women, who were on short-acting, intermediate-acting, or a combination of them, and opted to carry out Ramadan fasting. Glycemic control was assessed before, middle and after Ramadan fasting. Results: Thirty seven women opted to fast with 24 (64.9{\%}) of them had type 2 diabetes mellitus and 83.8{\%} of them required combined insulin (short- acting, intermediate-acting) therapy. The age of the participants was 32.13±4.68 years, and the age of their pregnancies was 25.60±7.12 weeks when the study was performed. The median number of days fasted was 25 days, and most of the women were able to fast for more than 15 days. There was no difference between glycemic control of type 2 diabetes mellitus and gestational diabetes mellitus women prior to fasting. In the middle of Ramadan, serum fructosamine decreased in both groups. However, only serum HbA1c reduced in gestational diabetes mellitus after Ramadan. Conclusion: the findings indicate that pregnant diabetic women on insulin were able to fast during Ramadan and that their glycemic control was improved during fasting period. They may also suggest that instead of absolute ban on fasting for pregnant diabetic women more practical approach and close consultation with health care providers might be more helpful.",
keywords = "Diabetes, Fasting, Insulin, Pregnancy gestational diabetes",
author = "{Mohamed Ismail}, {Nor Azlin} and Raji, {Hadijat Olaide} and {A. Wahab @ A. Rahman}, Norasyikin and Norlaila Mustafa and Kamaruddin, {Nor Azmi} and Jamil, {Muhammad Abdul}",
year = "2011",
month = "12",
language = "English",
volume = "36",
pages = "254--259",
journal = "Iranian Journal of Medical Sciences",
issn = "0253-0716",
publisher = "Shiraz University of Medical Sciences",
number = "4",

}

TY - JOUR

T1 - Glycemic control among pregnant diabetic women on insulin who fasted during Ramadan

AU - Mohamed Ismail, Nor Azlin

AU - Raji, Hadijat Olaide

AU - A. Wahab @ A. Rahman, Norasyikin

AU - Mustafa, Norlaila

AU - Kamaruddin, Nor Azmi

AU - Jamil, Muhammad Abdul

PY - 2011/12

Y1 - 2011/12

N2 - Background: Ramadan fasting for pregnant women with diabetes remains controversial and underreported. The objective of this study was to determine the glycemic control in pregnant diabetic women on insulin who fasted during Ramadan. Methods: This was a retrospective study carried out over a period of three years including pregnant diabetic women, who were on short-acting, intermediate-acting, or a combination of them, and opted to carry out Ramadan fasting. Glycemic control was assessed before, middle and after Ramadan fasting. Results: Thirty seven women opted to fast with 24 (64.9%) of them had type 2 diabetes mellitus and 83.8% of them required combined insulin (short- acting, intermediate-acting) therapy. The age of the participants was 32.13±4.68 years, and the age of their pregnancies was 25.60±7.12 weeks when the study was performed. The median number of days fasted was 25 days, and most of the women were able to fast for more than 15 days. There was no difference between glycemic control of type 2 diabetes mellitus and gestational diabetes mellitus women prior to fasting. In the middle of Ramadan, serum fructosamine decreased in both groups. However, only serum HbA1c reduced in gestational diabetes mellitus after Ramadan. Conclusion: the findings indicate that pregnant diabetic women on insulin were able to fast during Ramadan and that their glycemic control was improved during fasting period. They may also suggest that instead of absolute ban on fasting for pregnant diabetic women more practical approach and close consultation with health care providers might be more helpful.

AB - Background: Ramadan fasting for pregnant women with diabetes remains controversial and underreported. The objective of this study was to determine the glycemic control in pregnant diabetic women on insulin who fasted during Ramadan. Methods: This was a retrospective study carried out over a period of three years including pregnant diabetic women, who were on short-acting, intermediate-acting, or a combination of them, and opted to carry out Ramadan fasting. Glycemic control was assessed before, middle and after Ramadan fasting. Results: Thirty seven women opted to fast with 24 (64.9%) of them had type 2 diabetes mellitus and 83.8% of them required combined insulin (short- acting, intermediate-acting) therapy. The age of the participants was 32.13±4.68 years, and the age of their pregnancies was 25.60±7.12 weeks when the study was performed. The median number of days fasted was 25 days, and most of the women were able to fast for more than 15 days. There was no difference between glycemic control of type 2 diabetes mellitus and gestational diabetes mellitus women prior to fasting. In the middle of Ramadan, serum fructosamine decreased in both groups. However, only serum HbA1c reduced in gestational diabetes mellitus after Ramadan. Conclusion: the findings indicate that pregnant diabetic women on insulin were able to fast during Ramadan and that their glycemic control was improved during fasting period. They may also suggest that instead of absolute ban on fasting for pregnant diabetic women more practical approach and close consultation with health care providers might be more helpful.

KW - Diabetes

KW - Fasting

KW - Insulin

KW - Pregnancy gestational diabetes

UR - http://www.scopus.com/inward/record.url?scp=80955122659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80955122659&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:80955122659

VL - 36

SP - 254

EP - 259

JO - Iranian Journal of Medical Sciences

JF - Iranian Journal of Medical Sciences

SN - 0253-0716

IS - 4

ER -